File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Effects of recombinant overexpression of Bcl2 on the proliferation, apoptosis, and osteogenic/odontogenic differentiation potential of dental pulp stem cells

TitleEffects of recombinant overexpression of Bcl2 on the proliferation, apoptosis, and osteogenic/odontogenic differentiation potential of dental pulp stem cells
Authors
Keywordsosteogenic differentiation
dental pulp stem cells
Bcl2
Apoptosis
proliferation
Issue Date2016
Citation
Journal of Endodontics, 2016, v. 42, n. 4, p. 575-583 How to Cite?
Abstract© 2016 American Association of Endodontists.Introduction The therapeutic usefulness of dental pulp stem cells (DPSCs) is severely limited by low survivability upon transplantation in situ because of the presence of various proapoptotic factors within damaged/diseased tissues (ie, hypoxia and inflammation). One strategy to enhance the survivability of grafted DPSCs could be recombinant overexpression of antiapoptotic genes, such as the B-cell lymphoma 2 gene (Bcl2). Methods DPSCs were transfected with the Bcl2 and/or GFP gene. Cell density and mitotic activity of transfected DPSCs within in vitro culture were evaluated with the water soluble tetrazolium salt-8 (WST-8) and bromodeoxyuridine assay, respectively, whereas apoptosis was evaluated through the detection of cytoplasmic histone-associated DNA fragments. The osteogenic/odontogenic differentiation potential of these cells was evaluated with quantitative real-time polymerase chain reaction, alkaline phosphatase, and alizarin red staining. Results Bcl2-transfected DPSCs exhibited consistently higher cell densities than the GFP-transfected control within in vitro culture, and this was not because of the higher mitotic rate but was instead attributed to enhanced cell survivability because of the inhibition of apoptosis by Bcl2. Recombinant overexpression of Bcl2 inhibited the osteogenic/odontogenic potential of DPSCs, as indicated by lower levels of alkaline phosphatase activity and mineralized calcium deposition, together with the down-regulated expression of several key osteogenic/odontogenic gene markers including collagen I, osteocalcin, dentin matrix protein-1, bone sialoprotein, and alkaline phosphatase. Conclusions The results place a "caveat" or limitation on the use of recombinant Bcl2 overexpression as a therapeutic strategy for improving the survivability of grafted DPSCs in that the osteogenic/odontogenic potential of these cells may be compromised despite enhanced survival within the host.
Persistent Identifierhttp://hdl.handle.net/10722/236073
ISSN
2023 Impact Factor: 3.5
2023 SCImago Journal Rankings: 1.356
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHeng, Boon Chin-
dc.contributor.authorYe, Xin-
dc.contributor.authorLiu, Yuan-
dc.contributor.authorDissanayaka, Waruna Lakmal-
dc.contributor.authorCheung, Gary Shun Pan-
dc.contributor.authorZhang, Chengfei-
dc.date.accessioned2016-11-11T07:42:52Z-
dc.date.available2016-11-11T07:42:52Z-
dc.date.issued2016-
dc.identifier.citationJournal of Endodontics, 2016, v. 42, n. 4, p. 575-583-
dc.identifier.issn0099-2399-
dc.identifier.urihttp://hdl.handle.net/10722/236073-
dc.description.abstract© 2016 American Association of Endodontists.Introduction The therapeutic usefulness of dental pulp stem cells (DPSCs) is severely limited by low survivability upon transplantation in situ because of the presence of various proapoptotic factors within damaged/diseased tissues (ie, hypoxia and inflammation). One strategy to enhance the survivability of grafted DPSCs could be recombinant overexpression of antiapoptotic genes, such as the B-cell lymphoma 2 gene (Bcl2). Methods DPSCs were transfected with the Bcl2 and/or GFP gene. Cell density and mitotic activity of transfected DPSCs within in vitro culture were evaluated with the water soluble tetrazolium salt-8 (WST-8) and bromodeoxyuridine assay, respectively, whereas apoptosis was evaluated through the detection of cytoplasmic histone-associated DNA fragments. The osteogenic/odontogenic differentiation potential of these cells was evaluated with quantitative real-time polymerase chain reaction, alkaline phosphatase, and alizarin red staining. Results Bcl2-transfected DPSCs exhibited consistently higher cell densities than the GFP-transfected control within in vitro culture, and this was not because of the higher mitotic rate but was instead attributed to enhanced cell survivability because of the inhibition of apoptosis by Bcl2. Recombinant overexpression of Bcl2 inhibited the osteogenic/odontogenic potential of DPSCs, as indicated by lower levels of alkaline phosphatase activity and mineralized calcium deposition, together with the down-regulated expression of several key osteogenic/odontogenic gene markers including collagen I, osteocalcin, dentin matrix protein-1, bone sialoprotein, and alkaline phosphatase. Conclusions The results place a "caveat" or limitation on the use of recombinant Bcl2 overexpression as a therapeutic strategy for improving the survivability of grafted DPSCs in that the osteogenic/odontogenic potential of these cells may be compromised despite enhanced survival within the host.-
dc.languageeng-
dc.relation.ispartofJournal of Endodontics-
dc.subjectosteogenic differentiation-
dc.subjectdental pulp stem cells-
dc.subjectBcl2-
dc.subjectApoptosis-
dc.subjectproliferation-
dc.titleEffects of recombinant overexpression of Bcl2 on the proliferation, apoptosis, and osteogenic/odontogenic differentiation potential of dental pulp stem cells-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.joen.2016.01.013-
dc.identifier.scopuseid_2-s2.0-84958559743-
dc.identifier.hkuros257454-
dc.identifier.volume42-
dc.identifier.issue4-
dc.identifier.spage575-
dc.identifier.epage583-
dc.identifier.isiWOS:000373241900010-
dc.identifier.issnl0099-2399-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats